Our study found that compared with normal tissues, CTTNBP2, KIF18A, NAV1, SLAIN2, and TRIO were upregulated in glioma, while SRCIN1 and TTBK2 were downregulated. This evidence concerns the gene TRIO and central nervous system cancer.